Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/182964
Title: | Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality |
Author: | Loftfield, Erikka Stepien, Magdalena Viallon, Vivian Trijsburg, Laura Rothwell, Joseph A. Robinot, Nivonirina Biessy, Carine Bergdahl, Ingvar A. Bodén, Stina Schulze, Matthias B. Bergman, Manuela Weiderpass, Elisabete Schmidt, Julie A. Zamora-Ros, Raul Nøst, Therese Haugdahl Sandanger, Torkjel M. Sonestedt, Emily Ohlsson, Bodil Katzke, Verena Kaaks, Rudolf Ricceri, Fulvio Tjønneland, Anne Dahm, Christina C. Sánchez, Maria José Trichopoulou, Antonia Tumino, Rosario Chirlaque, María Dolores Masala, Giovanna Ardanaz, Eva Vermeulen, Roel Brennan, Paul Albanes, Demetrius Weinstein, Stephanie J. Scalbert, Augustin Freedman, Neal D. Gunter, Marc J. Jenab, Mazda Sinha, Rashmi Keski-Rahkonen, Pekka Ferrari, Pietro |
Keywords: | Alcohol Càncer Alcohol Cancer |
Issue Date: | 19-May-2021 |
Publisher: | Oxford University Press (OUP) |
Abstract: | Background: Alcohol is an established risk factor for several cancers, but modest alcohol-cancer associations may be missed because of measurement error in self-reported assessments. Biomarkers of habitual alcohol intake may provide novel insight into the relationship between alcohol and cancer risk. Methods: Untargeted metabolomics was used to identify metabolites correlated with self-reported habitual alcohol intake in a discovery dataset from the European Prospective Investigation into Cancer and Nutrition (EPIC; n = 454). Statistically significant correlations were tested in independent datasets of controls from case-control studies nested within EPIC (n = 280) and the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC; n = 438) study. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations of alcohol-associated metabolites and self-reported alcohol intake with risk of pancreatic cancer, hepatocellular carcinoma (HCC), liver cancer, and liver disease mortality in the contributing studies. Results: Two metabolites displayed a dose-response association with self-reported alcohol intake: 2-hydroxy-3-methylbutyric acid and an unidentified compound. A 1-SD (log2) increase in levels of 2-hydroxy-3-methylbutyric acid was associated with risk of HCC (OR = 2.54, 95% CI = 1.51 to 4.27) and pancreatic cancer (OR = 1.43, 95% CI = 1.03 to 1.99) in EPIC and liver cancer (OR = 2.00, 95% CI = 1.44 to 2.77) and liver disease mortality (OR = 2.16, 95% CI = 1.63 to 2.86) in ATBC. Conversely, a 1-SD (log2) increase in questionnaire-derived alcohol intake was not associated with HCC or pancreatic cancer in EPIC or liver cancer in ATBC but was associated with liver disease mortality (OR = 2.19, 95% CI = 1.60 to 2.98) in ATBC. Conclusions: 2-hydroxy-3-methylbutyric acid is a candidate biomarker of habitual alcohol intake that may advance the study of alcohol and cancer risk in population-based studies. |
Note: | Postprint del document publicat a: https://doi.org/10.1093/jnci/djab078 |
It is part of: | JNCI: Journal of the National Cancer Institute, 2021, vol 113, num 11, p. 1542-1550 |
URI: | http://hdl.handle.net/2445/182964 |
Related resource: | https://doi.org/10.1093/jnci/djab078 |
ISSN: | 1460-2105 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2021.03.12.20224451v1.full.pdf | 486.45 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.